Stimulation of phagocyte adhesion to endothelial cells by modified VLDL and HDL requires scavenger receptor BI.

about

Stimulation of phagocyte adhesion to endothelial cells by modified VLDL and HDL requires scavenger receptor BI.

Item

http://www.wikidata.org/entity/Q44926429

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Stimulation of phagocyte adhes ...... equires scavenger receptor BI.

@en

Stimulation of phagocyte adhes ...... equires scavenger receptor BI.

@nl

type

Item

label

Stimulation of phagocyte adhes ...... equires scavenger receptor BI.

@en

Stimulation of phagocyte adhes ...... equires scavenger receptor BI.

@nl

prefLabel

Stimulation of phagocyte adhes ...... equires scavenger receptor BI.

@en

Stimulation of phagocyte adhes ...... equires scavenger receptor BI.

@nl

P1476

Stimulation of phagocyte adhes ...... equires scavenger receptor BI.

@en

P2093

Juergen Graessler

http://www.w3.org/2001/XMLSchema#string

Sarama Saha

http://www.w3.org/2001/XMLSchema#string

Steffi Kopprasch

http://www.w3.org/2001/XMLSchema#string

P2860

Role of high-density lipoprotein and scavenger receptor B type I in the promotion of endothelial repair

Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems

Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI.

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I.

The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity.

Effects of electronegative VLDL on endothelium damage in metabolic syndrome.

Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.

Translating molecular discoveries into new therapies for atherosclerosis.

Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.

P2888

s11010-013-1749-9

P304

21-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11010-013-1749-9

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

383

http://www.w3.org/2001/XMLSchema#string

P50

Stefan R. Bornstein

Peter Schwarz

P577

2013-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23852455

http://www.w3.org/2001/XMLSchema#string

P921

endothelium